Upon antigen recognition, CTLs target tumor cells either directly through triggering synaptic exocytosis of cytotoxic granules comprising perforin and granzymes or indirectly through directing other immune components of tumor microenvironments toward tumor cells via secretion of cytokines, including IFNγ and TNF-α (148). The gene discussed is IFNG; the disease is neoplasm.